PET imaging of microglial pathology in multiple sclerosis

Key Points

• The study aims to evaluate microglial pathology in multiple sclerosis using PET imaging.
• Utilized PET imaging to assess brain inflammation in multiple sclerosis patients.
• Compared findings with MRI results to determine detection capabilities of each method.
• Evaluated glial responses to emerging neuroprotective therapies.
• PET imaging identified inflammation that MRI could not detect.
• Highlighted the role of microglial activity in the pathophysiology of MS.
• Demonstrated potential for PET to guide therapeutic strategies in MS.

Abstract